Browsing by Author "Cramer, G.E."

Now showing items 1-18 of 18

Acute rule-out of non-ST-segment elevation acute coronary syndrome in the (pre)hospital setting by HEART score assessment and a single point-of-care troponin: rationale and design of the ARTICA randomised trial
Aarts, G.W.A. ; Camaro, C. ; Geuns, R.J.M. van ; Cramer, E. ; Kimmenade, R.R.J. van ; Damman, P. ; Grunsven, P.M. van; Adang, E.M. ; Giesen, P.H. ; Rutten, M.H. ; Ouwendijk, O.; Gomes, M.E.R. ; Royen, N. van et al. sine al.
2020, Article / Letter to editor (BMJ Open, vol. 10, iss. 2, (2020), article e034403)
Cardiac troponin I is present in plasma of type 1 myocardial infarction patients and patients with troponin I elevations due to other etiologies as complex with little free I
Wijk, Xander M. R. van; Claassen, Stijn; Enea, Nicholas S.; Li, Pu; Yang, Samuel; Brouwer, M.A. ; Cramer, G.E. ; Lynch, Kara L.; Wu, Alan H.B.
2019, Article / Letter to editor (Clinical Biochemistry, vol. 73, (2019), pp. 35-43)
Multi-Site Coronary Vein Sampling Study on Cardiac Troponin T Degradation in Non-ST-Segment-Elevation Myocardial Infarction: Toward a More Specific Cardiac Troponin T Assay
Damen, S.A.J. ; Vroemen, Wim H.M.; Brouwer, M.A. ; Mezger, Stephanie T.P.; Suryapranata, H. ; Royen, N. van ; Verheugt, F.W.A. ; Cramer, G.E. ; Mingels, Alma M.A.
2019, Article / Letter to editor (Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, vol. 8, iss. 14, (2019), article e012602)
Temporal Pattern of Growth Differentiation Factor-15 Protein After Acute Coronary Syndrome (From the BIOMArCS Study)
Buljubasic, Nermina; Vroegindewey, Maxime M.; Oemrawsingh, Rohit M.; Asselbergs, F.W.; Cramer, E. ; Liem, Anho; Akkerhuis, K.Martijn; Boersma, E.
2019, Article / Letter to editor (American Journal of Cardiology, vol. 124, iss. 1, (2019), pp. 8-13)
Association between Lifelong Physical Activity and Disease Characteristics in HCM
Aengevaeren, V.L.; Gommans, D.H.F. ; Dieker, H.J. ; Timmermans, J. ; Verheugt, F.W.A. ; Bakker, Jeannette; Hopman, M.T.E. ; Boer, M.J. de ; Brouwer, M.A. ; Cramer, G.E. ; Eijsvogels, T.M.H. et al. sine al.
2019, Article / Letter to editor (Medicine and Science in Sports and Exercise, vol. 51, iss. 10, (2019), pp. 1995-2002)
The temporal pattern of immune and inflammatory proteins prior to a recurrent coronary event in post-acute coronary syndrome patients
Vroegindewey, Maxime M.; Oemrawsingh, Rohit M.; Kardys, Isabella; Asselbergs, F.W.; Harst, Pim van der; Oude Ophuis, A.J.; Cramer, G.E. ; Boersma, E.; Akkerhuis, K.Martijn
2019, Article / Letter to editor (Biomarkers, vol. 24, iss. 2, (2019), pp. 199-205)
Coronary artery spasms due to tyrosine kinase inhibitors used in chronic myeloid leukemia
Fiets, R.B.; Staal, A.H.J. ; Cramer, G.E. ; Blijlevens, N.M.A.
2018, Article / Letter to editor (Netherlands Journal of Medicine, vol. 76, iss. 7, (2018), pp. 330-335)
High T2-weighted signal intensity for risk prediction of sudden cardiac death in hypertrophic cardiomyopathy
Gommans, D.H.F. ; Cramer, G.E. ; Bakker, Jeannette; Dieker, H.J. ; Michels, Michelle; Fouraux, Michael A.; Marcelis, C.L.M. ; Verheugt, F.W.A. ; Timmermans, J. ; Brouwer, M.A. ; Kofflard, Marcel J.M. et al. sine al.
2018, Article / Letter to editor (International Journal of Cardiovascular Imaging, vol. 34, iss. 1, (2018), pp. 113-120)
Prediction of Extensive Myocardial Fibrosis in Nonhigh Risk Patients With Hypertrophic Cardiomyopathy
Gommans, D.H.F. ; Cramer, G.E. ; Fouraux, M.A.; Bakker, J. den; Michels, M; Dieker, H.J. ; Timmermans, J. ; Marcelis, C.L.M. ; Verheugt, F.W.A. ; Boer, M.J. de ; Kofflard, M.J.M.; Boer, R.A. de; Brouwer, M.A. et al. sine al.
2018, Article / Letter to editor (American Journal of Cardiology, vol. 122, iss. 3, (2018), pp. 483-489)
A multi-site coronary sampling study on CRP in non-STEMI: Novel insights into the inflammatory process in acute coronary syndromes
Damen, S.A.J. ; Cramer, G.E. ; Dieker, H.J. ; Gehlmann, H.R. ; Aengevaeren, W.R.M. ; Oude Ophuis, T.J.M.; Verheugt, F.W.A. ; Brouwer, M.A. ; Suryapranata, H.
2018, Article / Letter to editor (Atherosclerosis, vol. 278, (2018), pp. 117-123)
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
Ridker, P.M.; Revkin, J.; Amarenco, P.; Brunell, R.; Curto, M.; Civeira, F.; Flather, M.; Glynn, R.J.; Gregoire, J.; Jukema, J.W.; Karpov, Y.; Kastelein, J.J.; Koenig, W.; Lorenzatti, A.; Manga, P.; Masiukiewicz, U.; Miller, M.; Mosterd, A.; Murin, J.; Nicolau, J.C.; Nissen, S.; Ponikowski, P.; Santos, R.D.; Schwartz, P.F.; Soran, H.; White, H.; Wright, R.S.; Vrablik, M.; Yunis, C.; Shear, C.L.; Tardif, J.C.; Cramer, E. ; Riksen, N.P. ; et al. et al. sine al.
2017, Article / Letter to editor (The New England Journal of Medicine, vol. 376, iss. 16, (2017), pp. 1527-1539)
High T2-weighted signal intensity is associated with elevated troponin T in hypertrophic cardiomyopathy
Gommans, D.H.F. ; Cramer, G.E. ; Bakker, J.; Michels, M; Dieker, H.J. ; Timmermans, J. ; Fouraux, M.A.; Marcelis, C.L.M. ; Verheugt, F.W.A. ; Brouwer, M.A. ; Kofflard, M.J.M. et al. sine al.
2017, Article / Letter to editor (Heart, vol. 103, iss. 4, (2017), pp. 293-299)
Impact of the papillary muscles on cardiac magnetic resonance image analysis of important left ventricular parameters in hypertrophic cardiomyopathy
Gommans, D.H.F. ; Bakker, J.; Cramer, G.E. ; Verheugt, F.W.A. ; Brouwer, M.A. ; Kofflard, M.J.M.
2016, Article / Letter to editor (Netherlands Heart Journal, vol. 24, iss. 5, (2016), pp. 326-331)
Relation of highly sensitive cardiac troponin T in hypertrophic cardiomyopathy to left ventricular mass and cardiovascular risk
Cramer, G.E. ; Bakker, J.; Gommans, F. ; Brouwer, M.A. ; Kurvers, M.; Fouraux, M.; Verheugt, F.W.A. ; Kofflard, M.
2014, Article / Letter to editor (American Journal of Cardiology, vol. 113, iss. 7, (2014), pp. 1240-1245)
Highly sensitive cardiac troponin T and long-term mortality in a population of community-derived perimenopausal women: nested case-control study
Cramer, G.E. ; Brouwer, M.A. ; Vader, H.L.; Boer, M.J. de ; Pop, G.A.M. ; Pop, V.J.M.; Verheugt, F.W.A.
2013, Article / Letter to editor (Heart, vol. 99, iss. 8, (2013), pp. 528-533)
Vroege detectie van cardiotoxiciteit bij de behandeling met HER2-blokkerende middelen bij HER2-positieve mammacarcinoompatiënten door het gebruik van serumbiomarkers, 3D-echocardiografie en cardiale MRI.
Liesting, C.; Brugts, J.J.; Cramer, G.E. ; Bakker, J.; Kofflard, M.J.M.; Levin, M.
2011, Article / Letter to editor (Nederlands Tijdschrift voor Oncologie, vol. 8, (2011), pp. 170-175)
Lack of concordance between a rapid bedside and conventional laboratory method of cardiac troponin testing: impact on risk stratification of patients suspected of acute coronary syndrome.
Cramer, G.E. ; Kievit, P.C. ; Brouwer, M.A. ; Keijzer, M.H. de; Luijten, H.E.; Verheugt, F.W.A.
2007, Article / Letter to editor (Clinica Chimica Acta, vol. 381, iss. 2, (2007), pp. 164-166)
Troponin release at rest and after exercise in patients with hypertrophic cardiomyopathy and the role for betablockade.
Pop, G.A.M. ; Cramer, G.E. ; Timmermans, J. ; Bos, J.S.; Verheugt, F.W.A.
2006, Article / Letter to editor (Archivos de Cardiología de México, vol. 76, iss. 4, (2006), pp. 415-418)

Now showing items 1-18 of 18

Search Repository

Advanced Search

Browse

All of Repository

Radboud Repository

Browsing by Author "Cramer, G.E."

Search Repository

Browse

All of Repository